Skip to main content

Table 2 Summary of outcomes for each agent

From: Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis

Type of intervention Outcomes
TFG < 3 STR LVEF MACEs AEs
Events Total Events Total Mean SD Total Events Total Events Total
Adenosine 82 978 538 931 48.80 11.72 502 115 959 258 796
Anisodamine 18 184 140 184 58.78 10.31 208 11 208 29 158
Diltiazem 20 88 43 88 54.21 12.33 88 12 88 19 54
Nicorandil 7 207 33 57 55.18 11.75 112 20 148
Nitroprusside 57 551 191 317 51.46 12.44 199 26 363 50 317
Urapidil 1 27 25 27 54.32 6.65 49 0 27 4 27
Verapamil 26 181 34 79 52.56 12.48 181 18 151 3 30
Control 263 1693 608 1219 50.57 10.88 943 228 1478 87 1008
  1. TFG, TIMI flow grade; STR, ST-segment resolution; LVEF, left ventricular ejection fraction; MACEs, major adverse cardiovascular events; AEs, adverse events